Mumbai: ABH Healthcare Limited, which operates the Anil Baghi Hospital brand, has opened its ₹34.98-crore initial public offering.
The issue will close on August 27, 2026, and the company plans to list its shares on the NSE SME platform.
The price band has been fixed at ₹96-102 per equity share.
The IPO consists entirely of a fresh issue of 34,29,600 shares with a face value of ₹10 each through the book-building process.
The minimum application lot is 1,200 shares.
The offer includes 1,72,800 shares reserved for a market maker, leaving 32,56,800 shares for the public.
Also Read: ABH Healthcare IPO Opens August 24, GMP Signals Strong Interest
QIB Portion Subscribed
The qualified institutional buyers segment was subscribed 8.37 times, according to the company.
It received bids for around 16.67 lakh shares worth nearly ₹17 crore, compared with 1.99 lakh shares available.
ABH Healthcare said the demand reflected institutional confidence in its business fundamentals and growth prospects.
Grey Market Premium Rises
The company’s shares were commanding an unofficial grey market premium of around ₹55-60 per share, sharply higher than ₹25-30 a few days earlier.
Against the upper price band of ₹102, the latest grey market premium indicates a possible listing gain of approximately 55%.
However, grey market prices are unofficial, can change quickly and do not guarantee the actual listing price.
Also Read: Sensex Faces 78,000 Hurdle, Nifty Eyes 24,600 as Markets Stay Cautious
Use Of IPO Proceeds
ABH Healthcare plans to use ₹17 crore to repay or prepay certain borrowings and ₹5 crore for working capital.
Part of the remaining proceeds will fund unidentified acquisitions and general corporate purposes.
Fedex Securities is the book-running lead manager, while Bigshare Services is the registrar.
Financial Performance
Consolidated revenue increased from ₹41.38 crore in FY24 to ₹52.51 crore in FY26.
EBITDA more than doubled from ₹6.89 crore to ₹14.72 crore, while profit after tax rose from ₹1.66 crore to ₹5.64 crore.
The EBITDA margin expanded from 16.66% to 28.03% during this period.
Return on equity stood at 39.07% in FY26, showing a significant improvement in operating efficiency.
